Clinical guidance on gastrointestinal effects of GLP-1 receptor agonists
As a synthetic 39-amino acid peptide, Retatrutide (LY3437943) acts as a single-sequence multi-agonist with structural affinity for three distinct metabolic receptors: Gastric Inhibitory Polypeptide (GIP), Glucagon-Like Peptide-1 (GLP-1), and Glucagon (GCGR)
Insoluble fiber adds bulk and helps move waste through the intestines
Even if caloric intake remains similar, the metabolic effects can drive additional fat loss compared to GLP-1 only approaches
We break it all down in our visual guide below
However, two of the five named pharmacy partners have active FDA enforcement and state-board action, including warning letters, recalls, and pharmacist-license probation tied to counterfeit Ozempic